David A. Russler-Germain, MD, PhD

David A. Russler-Germain, MD, PhD is an instructor in medicine in the Division of Oncology, John T. Milliken Department of Medicine, at Washington University School of Medicine.

Articles by David A. Russler-Germain, MD, PhD

Dr Russler-Germain on the Potential Prognostic Value of ctDNA Status for EFS Outcomes in Lymphoma

ByDavid A. Russler-Germain, MD, PhD

Published: January 14th 2026 | Updated: January 14th 2026

David A. Russler-Germain, MD, PhD, discusses how data with MRD and ctDNA testing in solid tumors inform their potential application in hematologic malignancies.

David A. Russler-Germain, MD, PhD

Articles by David A. Russler-Germain, MD, PhD

Dr Russler-Germain on the Potential Prognostic Value of ctDNA Status for EFS Outcomes in Lymphoma

Latest Updated Articles

Trending on OncLive

ctDNA Status Has Strong Prognostic Value, Outperforming pCR Status, in Early TNBC

From Toilet Cleaner to Thoracic Oncologist and Patient: How Ross Camidge Built a Life Worth Loving

Breast Cancer Experts Spotlight Practice-Informing and Thought-Provoking Data From ASCO 2026

FDA Grants Priority Review to Giredestrant for ER-Positive Early Breast Cancer

CELMoDs and Bispecifics Break Through Across Lymphomas and Leukemias at EHA 2026